Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine dose comparison with neostigmine for neuromuscular blockade reversal in hypertensive patients
TCTR20180424004Phase 3Completed
- Sponsor
- Khon Kaen Hospital
- Start
- Oct 2017
- Modality
- Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atropine, neostigmine in hypertension (HTN), sponsored by Khon Kaen Hospital. Started Oct 2017; status: completed.
02
Drugs
atropineneostigmine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on TCTR20180424004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180424004.